MASCC/ISOO Study Group Workshop Application
MASCC 2015, Copenhagen, Denmark
Title of Workshop: Anemia in Cancer
Joint Workshop MASCC Neutropenia, Infection and
Myelosuppression Study Group MASCC in conjunction with Pediatric
Study Group
Name of Co-Chair of Workshop: Bernardo Rapoport, Jean Klastersky and
Marianne van de Wetering
Format of the program:
Plenary talks, debate, proffered papers and panel discussion
Program:
Session I: Pediatric Chair: Marianne van de Wetering
1. Case presentation: What to do if bloodtransfusions are not allowed in a
pediatric oncology patient - M van de Wetering
2. The role of erythropoetin in children with cancer - N Dors
3. Guidelines for anemia in children with cancer - E Loeffen
Session II: Adult Chair: Bernardo Rapoport and Jean Klastersky
1. Basic mechanism – Devan Moodley, South Africa
2. Anaemia in patients with solid tumours and haematological malignancies –
Bernardo Rapoport, South Africa
3. Differential diagnosis and work up of the cancer patient presenting with
anaemia – Georgia Demetriou, South Africa
4. Treatment of anaemia (including transfusions, role of IVI iron and the role of
ESA’s) - Jean Klastersky, Belgium
5. Current guidelines overview – Matti Aapro, Switzerland
6. Overview of studies looking at a decrease in survival - TBC
7. Cancer survival and QoL debate - Ron Feld, Canada and Rekha
Parameswaran, USA
8. Panel Discussion and Conclusion
Educational Objectives:
This workshop is intended to provide an update and give an overview on the
understanding of anemia in adult and pediatric patients with cancer. Special
attention will be given to controversial issues like:
 Negative impact on survival in patients with solid tumours receiving ESA’s,
 the role of transfusion and the timing of initiation of treatment with ESA’s
 special patient populations like Multiple Myeloma and other hematological
malignancies and post transplantation
 type of formulation and treatment and dosing schedules,
Cost-effectiveness and quality of life issues will also be discussed.